SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18495735
Source:
http://linkedlifedata.com/resource/pubmed/id/18495735
Search
Subject
(
89
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004083
,
umls-concept:C0005938
,
umls-concept:C0021368
,
umls-concept:C0030705
,
umls-concept:C0038013
,
umls-concept:C0243127
,
umls-concept:C0262950
,
umls-concept:C0443331
,
umls-concept:C0666743
,
umls-concept:C1280500
,
umls-concept:C2745888
pubmed:issue
2
pubmed:dateCreated
2009-1-13
pubmed:abstractText
To evaluate the relationship between bone mineral density (BMD) and biomarkers of bone turnover and inflammation in patients with ankylosing spondylitis (AS) treated with infliximab.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-10334678
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-10529140
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-10556657
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-10791618
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-11908565
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-12136902
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-12483748
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-12634235
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-15051621
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-15334477
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-15517638
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-15692973
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-16128948
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-16263785
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-16340635
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-16436492
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-16606653
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-18759257
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-18821688
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-7668898
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-8323382
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-9117174
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18495735-9598894
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
,
http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators
,
http://linkedlifedata.com/resource/pubmed/chemical/Osteocalcin
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1468-2060
pubmed:author
pubmed-author:BakerD GDG
,
pubmed-author:BraunJJ
,
pubmed-author:DeodharAA
,
pubmed-author:HanJJ
,
pubmed-author:VisvanathanSS
,
pubmed-author:WagnerCC
,
pubmed-author:van der HeijdeDD
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-82
pubmed:dateRevised
2010-9-21
pubmed:meshHeading
pubmed-meshheading:18495735-Absorptiometry, Photon
,
pubmed-meshheading:18495735-Adult
,
pubmed-meshheading:18495735-Aged
,
pubmed-meshheading:18495735-Aged, 80 and over
,
pubmed-meshheading:18495735-Alkaline Phosphatase
,
pubmed-meshheading:18495735-Antibodies, Monoclonal
,
pubmed-meshheading:18495735-Antirheumatic Agents
,
pubmed-meshheading:18495735-Biological Markers
,
pubmed-meshheading:18495735-Bone Density
,
pubmed-meshheading:18495735-Bone Remodeling
,
pubmed-meshheading:18495735-Cervical Vertebrae
,
pubmed-meshheading:18495735-Female
,
pubmed-meshheading:18495735-Humans
,
pubmed-meshheading:18495735-Inflammation Mediators
,
pubmed-meshheading:18495735-Lumbar Vertebrae
,
pubmed-meshheading:18495735-Male
,
pubmed-meshheading:18495735-Middle Aged
,
pubmed-meshheading:18495735-Osteocalcin
,
pubmed-meshheading:18495735-Spondylitis, Ankylosing
,
pubmed-meshheading:18495735-Young Adult
pubmed:year
2009
pubmed:articleTitle
Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis.
pubmed:affiliation
Centocor Research and Development, Inc., 200 Great Valley Parkway, Mailstop RA-1-4, Malvern, PA 19355, USA. svisvana@cntus.jnj.com
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial